Results 201 to 210 of about 882,867 (351)
European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action
European Journal of Heart Failure, EarlyView.Heart failure (HF) and atrial fibrillation (AF) are major global health challenges with rising prevalence and significant morbidity, mortality, and healthcare burden. Despite advances in HF management, AF remains a critical comorbidity that worsens outcomes and requires ad hoc treatment strategies, increasing the risk of non‐adherence and side effects. Mark Luedde, Stefan Agewall, Giuseppe Ambrosio, Antoni Bayes‐Genis, Claudio Borghi, Elisabetta Cerbai, Gheorghe A. Dan, Heinz Drexel, Péter Ferdinandy, Erik Lerkevang Grove, Juan Carlos Kaski, Roland Klingenberg, Joao Morais, William Parker, Mark C. Petrie, Bianca Rocca, Anne Grete Semb, Michele Senni, Christian Sohns, Patrick Sulzgruber, Juan Tamargo, Marco Metra, Michael Böhm, Dobromir Dobrev, Samuel Sossalla +24 morewiley +1 more sourceContemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM‐HF registry
European Journal of Heart Failure, EarlyView.Medical therapy use across the left ventricular ejection fraction spectrum in the OPTIPHARM‐HF registry. ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin II receptor blocker; ARNI, angiotensin receptor–neprilysin inhibitor; GDMT, guideline‐directed medical therapy; HF, heart failure; HFmrEF, heart failure with mildly reduced ejection ...Riccardo M. Inciardi, Maurizio Volterrani, Gianluigi Savarese, Muthiah Vaduganathan, Chiara Oriecuia, Carlo M. Lombardi, Cristina Gussago, Piergiuseppe Agostoni, Pietro Ameri, Giuseppe Armentaro, Chiara Arzilli, Nadia Aspromonte, Andrea Attanasio, Roberto Badagliacca, Lucia Barbieri, Pier Paolo Bocchino, Francesca Bursi, Matteo Cameli, Martino Canonero, Jeness S. Campodonico, Teresa Capovilla, Erberto Carluccio, Stefano Carugo, Vincenzo Castiglione, Dario Catapano, Manlio Cipriani, Michele Correale, Domenico D'Amario, Raffaele De Caterina, Gaetano M. De Ferrari, Emilia D'Elia, Luca Di Odoardo, Michele Emdin, Luigi Falco, Giulia Ferrante, Alessandra Fornaro, Paolo Fornaro, Gionata Guastamiglio, Marco Guazzi, Massimo Iacoviello, Massimo Imazio, Enrico Incaminato, Maria Teresa La Rovere, Sergio Leonardi, Marta Maccallini, Giulia E. Mandoli, Daniele Masarone, Marco Masetti, Alberto Mazzoni, Marta Mazzotta, Marco Merlo, Luigi Moschini, Filippo Novarese, Alberto Palazzuoli, Maria C. Pastore, Giuseppe Patti, Roberto F.E. Pedretti, Stefano Pidello, Massimo F. Piepoli, Giuseppe Pinto, Luciano Potena, Claudia Raineri, Filippo M. Rubbo, Mario Sabatino, Andrea Salzano, Angela Sciacqua, Michele Senni, Paolo Severino, Gianfranco Sinagra, Barbara Sposato, Stefano Taddei, Alessandro Valleggi, Carlo Vignati, Dario Vizza, Claudia Specchia, Giuseppe Rosano, Marco Metra, on behalf of the OPTIPHARM‐HF investigators, Marianna Adamo, Marilisa Ambrosio, Paolo Biagioli, Valeria Borelli, Natale Brunetti, Margherita Calcagnino, Giuseppe Caminiti, Francesco Canonico, Angelo Caporotondi, Velia Cassano, Ali Chraim, Valentina Codazzi, Giuliana Cimino, Francesco Clemenza, Giuditta Cuccuru, Giulia De Lio, Giandomenico Disabato, Marcello Divino, Salvatore D'Isa, Roberta Famiani, Enrica Fede, Letizia Fiòorentino, Alberto Foa', Paolo Fornaro, Noemi Furlotti, Nicolò Gallingani, Alberto Genova, Stefano Ghio, Federico Gobbi, Daniela Grassano, Lucia Guerisoli, Manuela Iseppi, Simona Leone, Ferdinando Loiacono, Valeria Luberto, Rossella Manai, Niccolò Manetti, Lina Manzi, Fabio Marsico, Francesco Maruca, Gabriele Masini, Irene Mattavelli, Ciro Mauro, Alberto Mazzoni, Marta Mazzotta, Pierre Meynet, Valentina Morsella, Giulia Nemola, Martina Niccolai, Savina Nodari, Matteo Pagnesi, Gianpaolo Palmieri, Alberto Panza, Francesca Parisi, Carlo Alberto Pastura, Anna Lisa Picerni, Riccardo Pilia, Ilaria Pirrone, Nicola R. Pugliese, Claudio Puteo, Federica Ramani, Gloria Santangelo, Laura Scelsi, Edoardo Sciatti, Lorenza Sforzini, Giulia Spoto, Davide Stolfo, Roberto Tarantini, Maria Cristina Tavera, Floriana Tortomasi, Eduardo Valente, Giuseppe Varricchione, Enrico Vizzardi, Greta Zagni, Mattia Zampieri +152 morewiley +1 more sourceUnsupervised machine learning for cardiovascular disease: A framework for future studies
European Journal of Heart Failure, EarlyView.Unsupervised machine learning can improve the characterization and stratification of patients with cardiovascular diseases (CVDs). Clustering algorithms, which group patients based on patterns in clinical data, can reveal distinct subgroups that may differ in prognosis and treatment response.Emmanuel Bresso, Claire Lacomblez, Kévin Duarte, Luca Monzo, Guillaume Baudry, Jasper Tromp, Abhinav Sharma, Nicolas Girerd +7 morewiley +1 more source
